Treating chronic hepatitis C in the primary care setting

被引:12
|
作者
McGinn, TG [1 ]
Gardenier, D [1 ]
McGinn, LK [1 ]
Alfandre, D [1 ]
O'Connor-Moore, N [1 ]
Sturm, TM [1 ]
Schiano, TD [1 ]
Reichman, S [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Div Gen Internal Med, New York, NY 10029 USA
关键词
access; comorbidity; hepatitis C; risk factor; treatment; primary care;
D O I
10.1055/s-2005-864782
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The National Institutes of Health and other institutions have emphasized the need to expand access to treatment of chronic hepatitis C virus infection to a larger and more diverse patient population. To begin to address this need, the divisions of General Internal Medicine and Liver Diseases of the Mount Sinai Medical Center created a program to identify patinets who might benefit from hepatitis C treatment, to treat uncomplicated patients in the primary care setting, and to refer appropriate patients to liver disease specialists. Preliminary data from this program suggest that primary care-based treatment of chronic hepatitis C may offer unique advantages. The primary care setting allows special needs to be addressed and allows comprehensive services to be provided. Patients are guided through the complex pretreatment evaluation process, and non-liver-related comorbidities are managed. Our program may provide a useful model for increasing hepatitis C literacy among primary care providers and for extending treatment to a broader population of patients with hepatitis C.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [41] Therapy of chronic hepatitis C in the setting of HIV co-infection
    Michielsen, P
    Bottieau, E
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (01) : 86 - 91
  • [42] Identifying Barriers to the Treatment of Chronic Hepatitis C Infection
    Al-Khazraji, Ahmed
    Patel, Ishan
    Saleh, Mohammed
    Ashraf, Amar
    Lieber, Joseph
    Malik, Raza
    DIGESTIVE DISEASES, 2020, 38 (01) : 46 - 52
  • [43] Screening of depression in patients with chronic medical diseases in a primary care setting
    Leung, KK
    Lue, BH
    Lee, MB
    Tang, LY
    FAMILY PRACTICE, 1998, 15 (01) : 67 - 75
  • [44] Treating substance use disorders in patients with hepatitis C
    Cucciare, Michael A.
    Cheung, Ramsey C.
    Rongey, Catherine
    ADDICTION, 2015, 110 (07) : 1057 - 1059
  • [45] Role of Behavioral Health Providers in Treating Hepatitis C
    Cos, Travis A.
    Bartholomew, Tyler S.
    Huynh, Katherine J.
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2019, 50 (04) : 246 - 254
  • [46] Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care? A narrative systematic review of the evidence base
    Brew, Iain F.
    Butt, Christine
    Wright, Nat
    BRITISH JOURNAL OF GENERAL PRACTICE, 2013, 63 (617) : E842 - E851
  • [47] Primary hepatic Burkitt's lymphoma with chronic hepatitis C
    Kuroda, J
    Omoto, A
    Fujiki, H
    Okugawa, K
    Tamai, H
    Yamagishi, H
    Kobayashi, Y
    Yoshikawa, T
    ACTA HAEMATOLOGICA, 2001, 105 (04) : 237 - 240
  • [48] PRIMARY HEPATIC LYMPHOMA IN A PATIENT WITH CHRONIC HEPATITIS-C
    RYAN, J
    WALLACE, S
    JONES, P
    TAGGART, G
    DUDLEY, F
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 9 (03) : 308 - 310
  • [49] Primary aldosteronism in the primary care setting
    Buffolo, Fabrizio
    Monticone, Silvia
    Tetti, Martina
    Mulatero, Paolo
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (03) : 155 - 159
  • [50] Nurse practitioners as primary care site champions for the screening and treatment of hepatitis C virus
    Dale, Cheryl H.
    Smith, Elizabeth
    Biondi, Mia J.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2022, 34 (04) : 688 - 695